FY21 Results: MND reported revenue of $1.95bn which is ~6% above expectations however profitability was a miss given margin issues, NPAT of $47.1m was a ~13% miss to consensus. The FY21 DPS of $0.45 was inline while guidance is now for lower revenue in FY22 – the market is positioned for a similar level. They talked to ongoing skill shortages with a review of their attraction & retention practices i.e. more money to keep good talent. We had NRW Holdings (NWH) report last week and rally ~20% on signs of better margins however MND have not enjoyed the same fate today. It’s clear that winning work is not the issue, fulfilling it is.
scroll
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Buy Hold Sell: The best and worst performers of FY25
Close
Wednesday 25th June – Dow +507pts, SPI up +5pts
Close
MM now has MND under review
Add To Hit List
Related Q&A
Reporting update on 3 stocks- CRN, CAJ and MVF
Why did MM choose WOR over MND?
When a stock is not marked ‘Active’
Our view on NRW Holdings & Monadelphous Group (MND)
MM stance on Monadelphous (MND)
Monadelphous Group (MND)
Relevant suggested news and content from the site

Video
WATCH
Buy Hold Sell: The best and worst performers of FY25
James Gerrish & Henry Jennings

Podcast
LISTEN
Wednesday 25th June – Dow +507pts, SPI up +5pts
Daily Podcast Direct from the Desk
Members only
UNLOCK MARKET MATTERS NOW
Take a free trial.
No payment details required.